Diagnos Laboratorium Utama Tbk. vs Nusantara Almazia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Nusantara Almazia Tbk. trades at Rp147 (market cap 320.84B, 4.71M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Nusantara Almazia Tbk. are close in size by market cap, and Nusantara Almazia Tbk. is more actively traded (4.71M versus 27.5K). Which is the better fit depends on your goals.
| DGNS | NZIA | |
|---|---|---|
Market Cap | 308B | 320.84B |
Volume | 27.5K | 4.71M |
Lot | 275 | 47.07K |
Turnover | 6.23M | 691.19M |
Average Price | 226.59 | 146.84 |
Value | 6.23M | 691.19M |
Indicative Equilibrium Price | 230 | 146 |
Indicative Equilibrium Volume | 110 | 141.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Nusantara Almazia Tbk (the "Company") was incorporated under Deed No. 24 dated November 26, 2007 made by Ukon Krisnajaya, S.H., S.Pn,.
Read more on NZIA →